-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"
Pharmaceutical Network Market Analysis" Recently, the Guangdong Provincial Drug Administration issued the Qingyuan City Market Supervision Authority on the cancellation of <> noticeAccording to the circular, the Drug Licenses of the three pharmacies were cancelledThe announcement showed that the three pharmacies were canceled for the reason that the certificates were expiredin fact, it is no longer an exception for Guangdong Province to cancel drugstore licencesAs early as May 9, the Guangdong Provincial Drug Administration issued a message that, according to the Guangdong Food and Drug Administration on the regulations on the cancellation of drug business licenses, as of April 30, 2020, the Bureau has written off three enterprises "drug business license", two of which have voluntarily applied for cancellation of the drug business license; Five pharmaceutical enterprises have offered to cancel the Drug Business License on their own initiative in accordance with the lawOne pharmaceutical business enterprise did not request a write-off, but its Drug Business License has lapsedThe Guangdong Drug Administration has been cancelled by the Guangdong Drug Administration in accordance with the law with out of its Drug Business License, according to the industry, in recent months, more than 10 pharmacies in Guangdong Province have applied to cancel the "drug business license." In addition to Guangdong, in recent years, the Drug Administration has issued a notice to drug stores to cancel the license to operate drugsfor example, on June 10, Yueyang City Market Supervision Bureau, in accordance with the company's application, in accordance with the relevant provisions to cancel the four chain pharmacies "drug business license"; On March 3, 16 enterprises in Yantai County filed an application for cancellation of the Drug Business License, which is now cancelled in accordance with the relevant provisions of the Measures for the Administration of Drug Business Licenses, and on June 3rd, hebi City Market Bureau issued an announcement of the cancellation of the Drug Business License No6 of 2020, and five pharmacies were soldaccording to incomplete statistics, only in early June, Jiangsu, Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi and other places about 50 pharmacies to cancel the license to withdraw from the marketIt is worth noting that in these pharmacies, the basic reason is that the enterprise actively applied for cancellation or due did not apply for a replacementin addition to opting to cancel their licenses, there are also pharmacies that choose to sellFor example, on May 9, Liaoning Chengda announced that it intends to transfer 100% of the shares of Chengda Fangyuan Pharmaceutical Group Co., Ltd through a public listing bid on the Dalian Property Exchange It was valued at RMB1,859 million is understood that the current large square line of stores up to 1507, covering Liaoning, Jilin, Hebei, Inner Mongolia, Shandong provinces and 19 cities Through its annual report, Cheng Dafang achieved sales revenue of RMB2,937 million in 2019, a decrease of 2.97% YoY, and realized pre-tax profit of RMB72.48 million, a decrease of 319.85% YoY for the reasons of Liaoning Chengda to sell the offline chain, its announcement also made it clear that in order to continuously enhance its sustainable development capacity, highlight the core industry, and further optimize the allocation of resources visible, now in addition to the monomer is not good to do, the big chain also encountered trouble The industry believes that the reasons behind it, on the one hand, with the implementation of centralized procurement, drug prices further reduced, profit margin compression, coupled with increasingly strengthened supervision, limited operations, pharmacy survival space is constantly compressed, naturally will choose to sell securities de-listing factors, on the other hand, by labor, rent, compliance costs and other factors, corporate profits are not as good as before, retail pharmacies lying on the ground to earn money era has passed All in all, nationally, the market reshuffle is intensifying.